Ashley Walpole
Family · Ruston, LANPI 1164804936
Payments from drug & device makers
Across 216 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$1K
- Insmed, Inc.$428
- Calliditas Therapeutics US Inc.$235
- ZOLL Respicardia, Inc.$173
- Boehringer Ingelheim$171
- plus $948 from 14 others
What the payments were for
- Grants$902%
- Food & beverage$4,17696%
- Education$822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 77 | $1,302 |
| AstraZeneca | 50 | $1,090 |
| Insmed, Inc. | 24 | $428 |
| Calliditas Therapeutics US Inc. | 14 | $235 |
| ZOLL Respicardia, Inc. | 2 | $173 |
| Boehringer Ingelheim | 11 | $171 |
| Regeneron Healthcare Solutions, Inc. | 5 | $161 |
| Inspire Medical Systems, Inc. | 2 | $160 |
| Itamar Medical Inc | 2 | $121 |
| Inogen, Inc. | 9 | $118 |
| Verona Pharma, Inc. | 3 | $75 |
| Neurocrine Biosciences, Inc. | 3 | $65 |
| Baxter Healthcare | 3 | $59 |
| Viatris Specialty LLC | 2 | $42 |
| Mylan Specialty L.p. | 2 | $39 |
| Sanofi | 2 | $33 |
| Boston Scientific | 2 | $32 |
| Genentech USA, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$135
- WatchPATONE$110
How this compares
$4,348 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 548 | $423,736 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 206 | $139,084 |
| Breo ElliptaFluticasone/Vilanterol | 74 | $34,707 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 68 | $34,186 |
| SymbicortBudesonide/Formoterol Fumarate | 81 | $23,565 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 41 | $23,322 |
| Spiriva RespimatTiotropium Bromide | 27 | $17,213 |
| EliquisApixaban | 27 | $16,442 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 457 | $14,449 |
| Advair HfaFluticasone Propion/Salmeterol | 35 | $11,427 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 20 | $9,600 |
| Spiriva HandihalerTiotropium Bromide | 18 | $8,880 |
| Arnuity ElliptaFluticasone Furoate | 22 | $5,806 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 12 | $4,988 |
| BreynaBudesonide/Formoterol Fumarate | 17 | $4,155 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $1,302 | $487,571685 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,090 | $167,637299 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat, Combivent Respimat | $171 | $60,999115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,610 family providers in Louisiana.
Other family in Ruston
- Ashlea HillRuston$169K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.